[Rosuvastatin and metformin decrease inflammation and oxidative stress in patients with hypertension and dyslipidemia].

Abstract

INTRODUCTION AND OBJECTIVES Both hypertension and dyslipidemia raise the risk of cardiovascular disease because they have proinflammatory effects and increase oxidative stress. The aim of this study was to evaluate the effects of rosuvastatin and metformin on inflammation and oxidative stress in patients with hypertension and dyslipidemia. METHODS This… (More)

Topics

6 Figures and Tables